Genentech will start a second Phase 3 clinical trial of crenezumab, an anti-Amyloid-beta antibody for treating Alzheimer’s disease that was…
Articles by Ana de Barros, PhD
Neurotrope has finished dosing and monitoring patients in a Phase 2 clinical trial to evaluate Bryostatin-1, the company’s lead…
Sleeping for more than nine hours each night may predict the risk of developing dementia, and people who sleep a lot…
A brain imaging technique called single photon emission computed tomography, or SPECT, can help clinicians differentiate between depression and a cognitive…
A decade-long study evaluating the impact of a brain training exercise on dementia, often associated with Alzheimer’s disease, was…
Speaking more than one language appears to help the brain resist the effects of Alzheimer’s disease (AD), according to a study by…
The Alzheimer’s Association – New York City Chapter will collaborate with the Delta Rho Omega chapter of Alpha Kappa…
Neuronascent has been issued a U.S. patent for methods of stimulating neurogenesis and/or inhibiting neuronal degeneration that have potential therapeutic applications…
Researchers at Georgetown University Medical Center (GUMC) are recruiting participants for a clinical trial to evaluate the cancer drug…
Meditating or listening to music may benefit adults with preclinical memory loss, including those at risk for Alzheimer’s disease (AD),…